These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 16784981)

  • 21. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
    Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.
    Santarpia L; Sherman SI; Marabotti A; Clayman GL; El-Naggar AK
    Hum Pathol; 2009 Jun; 40(6):827-33. PubMed ID: 19200582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.
    Na KY; Kim RM; Song EM; Lee JH; Lee J; Soh EY
    J Surg Oncol; 2012 Jan; 105(1):10-4. PubMed ID: 21826673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.
    Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
    Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.
    Couto JP; Prazeres H; Castro P; Lima J; Máximo V; Soares P; Sobrinho-Simões M
    J Clin Pathol; 2009 May; 62(5):414-21. PubMed ID: 19147628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.
    Shi YF; Zou MJ; Schmidt H; Juhasz F; Stensky V; Robb D; Farid NR
    Cancer Res; 1991 May; 51(10):2690-3. PubMed ID: 2021946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Specific amplification by PCR for N-ras mutation in thyroid follicular cartinoma].
    Taniyama M; Kaihara M
    Nihon Rinsho; 1994 Apr; 52(4):1075-80. PubMed ID: 8196166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma.
    Caria P; Dettori T; Frau DV; Di Oto E; Morandi L; Parmeggiani A; Tallini G; Vanni R
    Am J Surg Pathol; 2012 Sep; 36(9):1415-20. PubMed ID: 22895275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid.
    Castro P; Soares P; Gusmão L; Seruca R; Sobrinho-Simões M
    Oncogene; 2006 Aug; 25(33):4620-7. PubMed ID: 16532025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
    Bouras M; Parvaz P; Berger N; Paulin C; Revol A
    Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
    Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
    Mostoufi-Moab S; Labourier E; Sullivan L; LiVolsi V; Li Y; Xiao R; Beaudenon-Huibregtse S; Kazahaya K; Adzick NS; Baloch Z; Bauer AJ
    Thyroid; 2018 Jan; 28(1):60-67. PubMed ID: 29108474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
    Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
    Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene rearrangement and Chernobyl related thyroid cancers.
    Santoro M; Thomas GA; Vecchio G; Williams GH; Fusco A; Chiappetta G; Pozcharskaya V; Bogdanova TI; Demidchik EP; Cherstvoy ED; Voscoboinik L; Tronko ND; Carss A; Bunnell H; Tonnachera M; Parma J; Dumont JE; Keller G; Höfler H; Williams ED
    Br J Cancer; 2000 Jan; 82(2):315-22. PubMed ID: 10646883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.
    Volante M; Rapa I; Gandhi M; Bussolati G; Giachino D; Papotti M; Nikiforov YE
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4735-41. PubMed ID: 19837916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma.
    Howitt BE; Jia Y; Sholl LM; Barletta JA
    Thyroid; 2013 Oct; 23(10):1256-62. PubMed ID: 23477374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Sep; 459(3):265-76. PubMed ID: 21796448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
    Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
    Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.
    Nikiforova MN; Nikiforov YE
    Expert Rev Mol Diagn; 2008 Jan; 8(1):83-95. PubMed ID: 18088233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.